SUNPHARMAUpdated 1 Sept 2026, 3:08

Sun Pharmaceutical Ind L

SUNPHARMAUpdated 1 Sept 2026, 3:08

Market Cap

₹4,76,220Cr.

Current Price

₹1,985

High / Low

₹2,048/1,547

Stock P/E

150

ROE12.7%

ROCE14.8%

Book Value₹93.2

Face Value₹1.00

Dividend Yield0.81%

About

Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs). The company and its subsidiaries has various manufacturing facilities spread across the world with trading and other incidental and related activities extending to global market.[1]It is the largest pharmaceutical company in India.[2]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	82	94	129	214	178	180	170	99	125	159	186	179
Inventory Days	227	260	256	218	277	210	245	220	240	223	251	287
Days Payable	164	216	229	262	214	170	288	175	188	171	221	236
Cash Conversion Cycle	146	138	155	170	242	220	127	144	177	211	216	230
Working Capital Days	-278	-168	-227	-129	-95	-9	62	-26	131	182	-5	171
ROCE %	-6%	-3%	-0%	5%	8%	11%	4%	8%	17%	13%	17%	15%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 1 September 2026 at 3:08

SUN PHARMACEUTICAL IND L (SUNPHARMA) financials — quarterly results, P&L, cash flow, balance sheet, shareholding